Fortrea Holdings Past Earnings Performance

Past criteria checks 0/6

Fortrea Holdings has been growing earnings at an average annual rate of 2.2%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 0.6% per year.

Key information

2.2%

Earnings growth rate

-114.2%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate-0.6%
Return on equity-14.4%
Net Margin-7.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Fortrea Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:K67 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,976-2184280
30 Jun 243,015-2153980
31 Mar 243,077-913400
31 Dec 233,109-33370
30 Sep 232,895503850
30 Jun 232,9431273490
31 Mar 233,0111683220
31 Dec 223,0961932800
31 Dec 213,058983030
31 Dec 202,580-3592680

Quality Earnings: K67 is currently unprofitable.

Growing Profit Margin: K67 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: K67 is unprofitable, but has reduced losses over the past 5 years at a rate of 2.2% per year.

Accelerating Growth: Unable to compare K67's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: K67 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (5.4%).


Return on Equity

High ROE: K67 has a negative Return on Equity (-14.4%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies